aztreonam
      J - Antiinfectives For Systemic Use -> J01 - Antibacterials For Systemic Use -> J01D - Other Beta-Lactam Antibacterials -> J01DF - Monobactams -> J01DF01 - Aztreonam
    
          
        Administration category:
         Free
      
    
          
        Medicine group:
        antibacterial
      
    
    
          
        Brand name:
                  Cayston
              
      Standard dosages
| Weight | ROA | Load | Dosage | |
|---|---|---|---|---|
| ROA: inhalation | Load: - | Dosage: 75mg 3 dd | ||
| Comments: 15 min. - 4 uur voor toediening luchtwegverwijder toedienen | ||||
Dosage for "I" sensitivity
| Weight | ROA | Load | Dosage | 
|---|---|---|---|
| ROA: iv | Load: - | Dosage: 2000mg 4 dd | 
Kidney function
Notes GFR general:
10–30 ml/min IV: 1–2 g loading dose; then maintenance of 50% of appropriate normal dose. Nebulised: dose as in normal renal function.
            <10 ml/min IV: 1–2 g loading dose; then maintenance of 25% of appropriate normal dose. Nebulised: dose as in normal renal function.
              
                Renal elimination: 
                75-80%
              
            
                    
                                
              
                Dosage: 
                dependent on kidney function
              
            
                    
        Renal function-replacement therapy
CAPD: geen gegevens bekend
Hemo dialysis: geen gegevens bekend
Pregnancy
Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Zwangerschap#TOC_Middelen_bij6
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Borstvoeding#TOC_Middelen_bij16
          
            For individual advice, consult an expert on site.          
        
      Metadata
            Swab vid: M-287649.4
            Updated: 11/01/2024 - 16:20
            Status: Published
          
